流行性感冒的防治进展(6)
6.Jefferson T, Demicheli V, Deeks J, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2000;(2):CD001265.
7.Demicheli V, Jefferson T, Rivetti D, et al. Prevention and early treatment of influenza in healthy adults.Vaccine 2000 Jan 6;18(11-12):957-1030.
8.邓伟吾和时国朝. 肺炎链球菌疫苗和流感病毒疫苗应用状况. 感染性疾病新动态 1998； 1(4)：1-4.
9.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices(ACIP). MMWR 2000; 49: 1-38.
10.Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in heath care professionals: a randomised trial. JAMA 1999;281:908-913.
11.Gubareva LV, Kaiser L, Hayden F. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 827-35.
12.Treanor JJ, Hayden F,Vrooman PS, et al. Efficacy and Safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. JAMA 2000;283(8):1016-1024.
13.Nicholson KG, Aoki FY, Osterhaus ADME, et al. Efficacy and safety of Oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000; 355: 1845-1850.
14.Whitley, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis 2001; 20: 127-33.
15.Bridges CB, Fukuda K, Cox NJ, et al. Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001;50(RR-4):1-44.
HYS-MD-WM
2002-10-30, http://www.100md.com(时国朝 邓伟吾)
7.Demicheli V, Jefferson T, Rivetti D, et al. Prevention and early treatment of influenza in healthy adults.Vaccine 2000 Jan 6;18(11-12):957-1030.
8.邓伟吾和时国朝. 肺炎链球菌疫苗和流感病毒疫苗应用状况. 感染性疾病新动态 1998； 1(4)：1-4.
9.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices(ACIP). MMWR 2000; 49: 1-38.
10.Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in heath care professionals: a randomised trial. JAMA 1999;281:908-913.
11.Gubareva LV, Kaiser L, Hayden F. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 827-35.
12.Treanor JJ, Hayden F,Vrooman PS, et al. Efficacy and Safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. JAMA 2000;283(8):1016-1024.
13.Nicholson KG, Aoki FY, Osterhaus ADME, et al. Efficacy and safety of Oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000; 355: 1845-1850.
14.Whitley, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis 2001; 20: 127-33.
15.Bridges CB, Fukuda K, Cox NJ, et al. Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001;50(RR-4):1-44.
HYS-MD-WM
2002-10-30, http://www.100md.com(时国朝 邓伟吾)